CoChat

Cholesterol trafficking is required for mTOR activation in endothelial cells

Open access
Xu, Jing, Dang, Yongjun, Ren, Yunzhao R., Liu, Jun O. · 2010 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Mammalian target of rapamycin (mTOR) constitutes a nodal point of a signaling network that regulates cell growth and proliferation in response to various environmental cues ranging from growth factor stimulation to nutrients to stress. Whether mTOR is also affected by cholesterol homeostasis, however, has remained unknown. We report that blockade of cholesterol trafficking through lysosome by a newly identified inhibitor of angiogenesis, itraconazole, leads to inhibition of mTOR activity in endothelial cells. Inhibition of mTOR by itraconazole but not rapamycin can be partially restored by extracellular cholesterol delivered by cyclodextrin. Moreover, other known inhibitors of endosomal/lysosomal cholesterol trafficking as well as siRNA knockdown of Niemann–Pick disease type C (NPC) 1 and NPC2 also cause inhibition of mTOR in endothelial cells. In addition, both the accumulation of cholesterol in the lysosome and inhibition of mTOR caused by itraconazole can be reversed by thapsigarin. These observations suggest that mTOR is likely to be involved in sensing membrane sterol concentrations in endothelial cells, and the cholesterol trafficking pathway is a promising target for the discovery of inhibitors of angiogenesis.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0910872107

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Cited by

See all 209

Metadata

Authors
Xu, J., Dang, Y., Ren, Y. R., & Liu, J. O.
Affiliations
Johns Hopkins University (US)
Corresponding author
Liu, Jun O.
Venue
Proceedings of the National Academy of Sciences
Published
2010-03-09
Volume
107
Issue
10
Pages
4764-4769
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2048629875
Cited by
209
References
39
Citations by year
2026: 6 · 2025: 8 · 2024: 8 · 2023: 13 · 2022: 9 · 2021: 14 · 2020: 16 · 2019: 14 · 2018: 15 · 2017: 17 · 2016: 15 · 2015: 14 · 2014: 14 · 2013: 8 · 2012: 25
FWCI
5.99
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • W. M. Keck Foundation
  • Flight Attendant Medical Research Institute
  • National Cancer Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
mTOR, cholesterol transport, lysosomal cholesterol, endothelial cells, itraconazole, angiogenesis inhibitors, Niemann-Pick disease type C, NPC1, NPC2, cyclodextrins, membrane sterols, cholesterol homeostasis
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Niemann-Pick C1 Protein, Androstenes, Biological Transport, Carrier Proteins, Cell Cycle, Cell Line, Cholesterol, Cyclodextrins, Enzyme Inhibitors, Humans, Imipramine, Membrane Glycoproteins, Proteins, Transcription Factors, Blotting, Western, Protein Serine-Threonine Kinases, Itraconazole, Thapsigargin, RNA Interference, Endothelial Cells, Multiprotein Complexes, Intracellular Signaling Peptides and Proteins, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase Inhibitor p27, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cholesterol trafficking is required for mTOR activation in endothelial cells. https://app.cochat.ai/papers/10.1073/pnas.0910872107
The paper
Xu, J., Dang, Y., Ren, Y. R., & Liu, J. O. (2010). Cholesterol trafficking is required for mTOR activation in endothelial cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0910872107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.